-
Mashup Score: 4
Journal of Asthma, Volume 61, Issue 5, May 2024 This new issue contains the following articles:Review ArticleRisk factors associated with uncontrolled asthma in children – a systematic review and meta-analysisMuhammad Imran Arif, MD (Pediatrics), Liang Ru, PhD (Pediatrics) & Yanan Wang, MSc (Pediatrics)P …
Source: interasma.orgCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 12Improving asthma control in young adults - 6 day(s) ago
Here’s a surprising statistic: Nearly 50% of people with asthma do not take their medications as prescribed. That means they risk a flare-up of symptoms or a visit to the emergency room. Asthma researchers …
Source: medicalxpress.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 6Childhood Asthma | Does my child have asthma? | AAAAI - 6 day(s) ago
Information about symptoms of childhood asthma written and reviewed by leading experts in allergy, asthma and immunology.
Source: www.aaaai.orgCategories: General Medicine News, Allergy-ImmunologyTweet-
Although there is no way to predict which children will develop asthma, studies have identified certain predictors for asthma in children. Uncontrolled asthma in children can result in permanent lung damage. But for most, asthma can be controlled. #asthma https://t.co/d3oSqcZaKl https://t.co/LWMQV7Lqte
-
-
Mashup Score: 5Asthma in children: Researchers envision novel drug to reduce the risk of the disease - 8 day(s) ago
Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 14Inhaled Asthma Medications | AAAAI - 15 day(s) ago
AAAAI, the experts in allergy and immunology, provide an overview of inhaled asthma medications and asthma inhalers.
Source: www.aaaai.orgCategories: General Medicine News, Allergy-ImmunologyTweet-
The goal of #asthma medications is to prevent symptoms from happening. There are two classes of asthma medications: quick-relief & long-term/control. Many inhaled meds are meant to be used daily to keep airways healthy, even if you are not having symptoms. https://t.co/d6UEdkJNfd https://t.co/8FzITltjEi
-
-
Mashup Score: 0Around 25% of Mild Asthma Patients Not Given Guideline-Directed Therapy, Despite Updates - 16 day(s) ago
This analysis highlights trends following the significant update made to the Global Initiative for Asthma and the National Heart Lung and Blood Institute asthma guidelines.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Around 25% of Mild Asthma Patients Not Given Guideline-Directed Therapy, Despite Updates - 18 day(s) ago
This analysis highlights trends following the significant update made to the Global Initiative for Asthma and the National Heart Lung and Blood Institute asthma guidelines.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11
Collaboration combines Teva’s expertise in respiratory technology development and Launch Therapeutics’ innovative late-stage drug development model to progress Teva’s Dual-Action Asthma Rescue Inhaler (TEV-‘248) program Development funding agreement to provide up to $150 million to offset program costs and to accelerate clinical research for Teva’s TEV-‘248 program in line with Teva’s Pivot to Growth strategy to step up innovation and advance its innovative pipeline Teva’s TEV-‘248 has the potential to be the first Dual-Action Asthma Rescue Inhaler combining an Inhaled Corticosteroid with a Short-Acting Beta-Agonist (ICS-SABA) for both adult and pediatric asthma indications Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248). Teva and Abingworth, a leading international life sciences investment group, part of global
Source: ir.tevapharm.comCategories: General Medicine News, PayerTweet-
Today Teva announced a clinical collaboration agreement with Launch Therapeutics and a strategic funding development agreement with @Abingworthbio to accelerate development of our dual-action asthma rescue inhaler respiratory program. Read more: https://t.co/0KqB2lyypD #Asthma https://t.co/ZdDurPB4dt
-
-
Mashup Score: 12Combinations of air pollutants impact pediatric asthma symptoms - 25 day(s) ago
Researchers used machine learning to identify 25 combinations of air pollutants that were associated with increased asthma symptoms among children in Spokane, Washington, according to a study published in Science of the Total Environment.Also, a vulnerable sub-population was exposed to 13 of these combinations, Solmaz Amiri, DDes, MSc, research assistant professor, Institute for Research and
Source: www.healio.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 4
Review Articles Medication Non-adherence and predictor factors among adult Asthmatic patients in Ethiopia: a Systematic review and Meta-AnalysisChernet Tafere, Bereket Bahiru, Adane Yehualaw, Desalegn Getnet Demsie, Kebede Feyisa, Malede Berihun Yismaw, Endalamaw Aschale, Zenaw De …
Source: interasma.orgCategories: General Medicine News, Allergy-ImmunologyTweet
RT @Interasma: Journal of #Asthma, Volume 61, Issue 5, May 2024 is now available online. https://t.co/xLNH7mqhRQ https://t.co/McUSGwOA3q